Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
about
The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis.CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African AmericansDextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability.Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.Initialization of adjuvant hormonal treatment for breast cancer.Pharmacologic approaches to the treatment of Huntington's disease.Cytochrome P450 pharmacogenetics in African populations.Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.Assessment of in vivo CYP2D6 activity: differential sensitivity of commonly used probes to urine pH.Evaluation of CYP2D6 phenotype in the Yoruba Nigerian population.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Metabolites: novel therapeutics or "me-too" drugs? Using desvenlafaxine as an example.CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
P2860
Q33924143-68466939-620D-4F3B-9BD3-A23BFC2DAD0DQ34125166-B7BC8EB6-A839-4B35-A2C1-1172D7721F11Q34331552-203F5D2F-CE27-4548-BC84-468B5C1A4033Q34546846-03E9FF2F-1CE0-409C-A49D-45ECF52CF6C3Q36675422-1A35E190-6E97-481B-8EBC-E5DCDBB9193BQ37236959-44A2E558-417A-466B-AA5D-E3CD1C0E8330Q37807282-A3B0B8B2-3B51-4CE4-BA85-2CEBF445B080Q37933168-5E8E3F36-CD85-43DB-8B6A-FE64A53F9EF5Q37945478-A93735ED-9836-4AD2-8EF4-1CF83C502B69Q38099372-6682BB19-078D-40B9-BCE6-5623089A0533Q43864975-5233E151-EE27-498C-8E7A-6A98910B78ACQ45040972-450225EF-E247-4154-9785-B836C493D689Q45151691-863A6CB4-6355-4BA8-8932-7BBD91754B74Q46506742-F2E30116-F25E-419E-AC06-D92522B9664CQ47566249-191A6660-175D-4825-BDA9-C3B427743E3BQ48633816-5DD86AE3-4724-4BC4-AD49-34FD55DA829AQ54605695-14FC5160-1598-473A-BF47-B32219D9B057
P2860
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
description
article
@en
im August 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1998
@uk
ലേഖനം
@ml
name
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@en
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@nl
type
label
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@en
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@nl
prefLabel
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@en
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@nl
P2093
P1476
Comparison of three CYP2D6 pro ...... naians, Chinese and Caucasians
@en
P2093
Andrea Gaedigk
Edward M. Sellers
Kofi Bruce-Mensah
Kurt Droll
Rachel F. Tyndale
S Victoria Otton
P304
P356
10.1097/00008571-199808000-00006
P577
1998-08-01T00:00:00Z